PhD positions in TB, HIV and TB/HIV PK/PD modelling

The Division of Clinical Pharmacology at the University of Cape Town, South Africa has received grant funding for TWO PhD positions to study pharmacokinetics and pharmacodynamics of first- and second-line drugs in the relevant patient populations with tuberculosis. A substantial focus of the projects will involve population non-linear mixed effects modeling. Our Division has established clinical and pharmacokinetic expertise in TB, HIV and TB/HIV. We have a young and dynamic modeling group supported by ongoing collaborations with more experienced groups in Europe and Australasia. We are actively engaged in the design and conduct of several research projects generating data in the relevant patient populations and volunteers. The group focus includes pharmacokinetic drug-drug and drug-disease interactions in children and adults co-infected with TB and HIV, and optimizing dosing strategies for TB and HIV treatments. The posts offer good opportunities for teaching and leadership. The positions are available for one year with possibility of extension to a total of 3 years according to mutual agreement. The successful candidates should have a Masters degree or equivalent (e.g. MBChB/ B Pharm), or be expected to receive one soon, in a relevant subject area (e.g. biostatistics, engineering, health sciences), proficiency with operating computers is essential and experience with statistics or computer modeling an advantage. Please apply to the address below with CV and a letter of interest by 28 September 2008. The successful candidates would be expected to be available from 5 January 2009. Address queries and applications to Dr Helen McIlleron: [EMAIL PROTECTED] OR Division of Clinical Pharmacology, UCT K-45 Old Main Building Groote Schuur Hospital Observatory 7925 Cape Town South Africa The Division of Clinical Pharmacology at the University of Cape Town, South Africa has received grant funding for TWO PhD positions to study pharmacokinetics and pharmacodynamics of first- and second-line drugs in the relevant patient populations with tuberculosis. A substantial focus of the projects will involve population non-linear mixed effects modeling. Our Division has established clinical and pharmacokinetic expertise in TB, HIV and TB/HIV. We have a young and dynamic modeling group supported by ongoing collaborations with more experienced groups in Europe and Australasia. We are actively engaged in the design and conduct of several research projects generating data in the relevant patient populations and volunteers. The group focus includes pharmacokinetic drug-drug and drug-disease interactions in children and adults co-infected with TB and HIV, and optimizing dosing strategies for TB and HIV treatments. The posts offer good opportunities for teaching and leadership. The positions are available for one year with possibility of extension to a total of 3 years according to mutual agreement. The successful candidates should have a Masters degree or equivalent (e.g. MBChB/ B Pharm), or be expected to receive one soon, in a relevant subject area (e.g. biostatistics, engineering, health sciences), proficiency with operating computers is essential and experience with statistics or computer modeling an advantage. Please apply to the address below with CV and a letter of interest by 28 September 2008. The successful candidates would be expected to be available from 5 January 2009. Address queries and applications to Dr Helen McIlleron: [EMAIL PROTECTED] OR Division of Clinical Pharmacology, UCT K-45 Old Main Building Groote Schuur Hospital Observatory 7925 Cape Town South Africa ______________________________________________________________________________________________ UNIVERSITY OF CAPE TOWN This e-mail is subject to the UCT ICT policies and e-mail disclaimer published on our website at http://www.uct.ac.za/about/policies/emaildisclaimer/ or obtainable from +27 21 650 4500. This e-mail is intended only for the person(s) to whom it is addressed. If the e-mail has reached you in error, please notify the author. If you are not the intended recipient of the e-mail you may not use, disclose, copy, redirect or print the content. If this e-mail is not related to the business of UCT it is sent by the sender in the sender's individual capacity. _____________________________________________________________________________________________________